Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Pancreas Cancer
54%
Malignant Neoplasm
33%
Pancreas Adenocarcinoma
33%
Nanoparticle
28%
Pancreas Tumor
22%
Immune Checkpoint Inhibitor
18%
Randomized Controlled Trial
16%
Antioxidant Capacity
16%
Polyphenol
16%
Solid Lipid Nanoparticle
16%
Small Interfering RNA
16%
Hypoxia
16%
Gemcitabine
16%
Vasopressin Receptor
16%
Argipressin
16%
Hematoporphyrin
15%
Cathepsin B
11%
Tumor Model
8%
MF1 Mouse
8%
Cuniculidae
8%
Phloroglucinol
8%
Sulfate
8%
Bioavailability
8%
Liver Injury
8%
Reactive Oxygen Metabolite
7%
Cytokine
7%
Cytotoxicity
7%
Biodistribution
5%
Immunosuppressive Agent
5%
Copolymer
5%
Monotherapy
5%
Side Effect
5%
Glutamic Acid
5%
Dimer
5%
C Reactive Protein
5%
Maltodextrin
5%
Biological Marker
5%
Placebo
5%
Glucuronide
5%
Medicine and Dentistry
Neoplasm
81%
Sonodynamic Therapy
72%
Pancreas Cancer
54%
Nanoparticle
42%
Programmed Death-Ligand 1
33%
Beta Cell
20%
Immune Checkpoint Inhibitor
19%
Diabetes
18%
Glucagon
18%
Gemcitabine
16%
Hypoxia
16%
Clinical Oncology
16%
Argipressin
16%
Cancer Research
16%
Small Interfering RNA
16%
Pancreas Tumor
16%
Conjugate
16%
Glucose Tolerance
16%
Pancreas Adenocarcinoma
16%
Reactive Oxygen Species
11%
Xenograft
10%
Tumor Model
9%
Malignant Neoplasm
8%
Liver Injury
8%
Glucagon Release
5%
Immunology and Microbiology
Programmed Death-Ligand 1
33%
Vasopressin
16%
Secretory Cell
16%
Arginine Vasopressin
16%
Adaptive Immune System
11%
CD8
5%
CD4
5%
Microbubble
5%
T Cell
5%
